{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.",
    "Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.",
    "UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.",
    "Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.",
    "Case Comprehensive Cancer Center, Cleveland, OH, USA.",
    "Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Albert Jang",
      "orcid": "0000-0002-0461-6174"
    },
    {
      "affs": [
        2
      ],
      "name": "Beaux Mitchell"
    },
    {
      "affs": [
        3,
        4
      ],
      "name": "Jason R Brown",
      "orcid": "0000-0001-6225-7555"
    },
    {
      "affs": [
        2,
        5
      ],
      "name": "Vadim S Koshkin",
      "orcid": "0000-0003-2277-8668"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/cscss2nnsnjje.bib",
  "cited_by": 0,
  "doi": "10.21037/tau-2026-0649",
  "fulltext_url": "https://europepmc.org/articles/PMC13741049",
  "id": "cscss2nnsnjje",
  "issns": [
    "2223-4691"
  ],
  "landing_url": "https://europepmc.org/article/MED/42997194",
  "language": "eng",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2746|Bladder and Urothelial Cancer Treatments"
    ]
  ],
  "openalex": "W7223942293",
  "pdf_url": "https://europepmc.org/articles/PMC13741049?pdf=render",
  "pmcid": "PMC13741049",
  "pmid": "42997194",
  "published": "2026-10-22",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/cscss2nnsnjje.ris",
  "sources": [
    {
      "first_seen": "2026-11-09T15:20:41Z",
      "native_id": "MED:42997194",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42997194"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2746|Bladder and Urothelial Cancer Treatments",
      "subfield": "surgery"
    }
  ],
  "title": "Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond.",
  "title_text": "Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond.",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T15:20:41Z",
  "url": "https://research.draconitic.com/paper/cscss2nnsnjje",
  "venue": "Translational andrology and urology",
  "versions": []
}